Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus: Five-Year Survival of a Randomized Clinical Trial
By J. Omloo, S. M. Lagarde, J. Hulscher, J. B. Reitsma, P. Fockens, H. Dekken, F. Kate, Huug Obertop, H W. Tilanus, J. J. B. Lanschot. Annals of Surgery, 2007
716 citations recorded by the source corpus.
Subfields: Gastroenterology, Surgery
View Paper: https://www.semanticscholar.org/paper/7b6dd7d5942ecc65ff03e13b69fa6e6ed62cce7c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Surgery
Citations in the corpus
- Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2013, background): “One randomised study showed a non-significant improvement in long-term survival for extended transthoracic compared with transhiatal resection [7], but this benefit appears to be restricted to patients with AC of the lower oesophagus (type I according to Siewert classification) [8].”
- Esophageal cancer. (2008, background): “This rate is not largely different from the reported 5-year survival rates after surgery.(2,3) Bedenne and colleagues(50) randomized 259 patients who had T3N0-1M0 esophageal cancer (89% ESCC) and who had responded to two courses of CRT to surgery alone (arm A) or to another three cycles of CRT (arm ”